Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES PHARMA SCIENCE GSK PHARMA STRIDES PHARMA SCIENCE/
GSK PHARMA
 
P/E (TTM) x -1,455.3 62.2 - View Chart
P/BV x 3.3 18.9 17.4% View Chart
Dividend Yield % 0.2 1.6 11.6%  

Financials

 STRIDES PHARMA SCIENCE   GSK PHARMA
EQUITY SHARE DATA
    STRIDES PHARMA SCIENCE
Mar-23
GSK PHARMA
Mar-23
STRIDES PHARMA SCIENCE/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs3921,684 23.3%   
Low Rs2631,231 21.4%   
Sales per share (Unadj.) Rs408.5191.9 212.8%  
Earnings per share (Unadj.) Rs-25.635.9 -71.3%  
Cash flow per share (Unadj.) Rs1.439.8 3.4%  
Dividends per share (Unadj.) Rs1.5032.00 4.7%  
Avg Dividend yield %0.52.2 20.8%  
Book value per share (Unadj.) Rs242.8102.9 236.0%  
Shares outstanding (eoy) m90.30169.41 53.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.87.6 10.6%   
Avg P/E ratio x-12.840.6 -31.6%  
P/CF ratio (eoy) x239.636.7 653.7%  
Price / Book Value ratio x1.414.2 9.5%  
Dividend payout %-5.989.2 -6.6%   
Avg Mkt Cap Rs m29,603246,858 12.0%   
No. of employees `000NANA-   
Total wages/salary Rs m7,3205,950 123.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m36,88432,517 113.4%  
Other income Rs m1,3521,007 134.3%   
Total revenues Rs m38,23633,524 114.1%   
Gross profit Rs m8308,033 10.3%  
Depreciation Rs m2,433658 369.9%   
Interest Rs m2,61118 14,411.8%   
Profit before tax Rs m-2,8628,364 -34.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-5532,288 -24.2%   
Profit after tax Rs m-2,3096,076 -38.0%  
Gross profit margin %2.224.7 9.1%  
Effective tax rate %19.327.4 70.6%   
Net profit margin %-6.318.7 -33.5%  
BALANCE SHEET DATA
Current assets Rs m31,35324,943 125.7%   
Current liabilities Rs m29,90213,264 225.4%   
Net working cap to sales %3.935.9 10.9%  
Current ratio x1.01.9 55.8%  
Inventory Days Days7197 73.1%  
Debtors Days Days129216 59.5%  
Net fixed assets Rs m31,3006,988 447.9%   
Share capital Rs m9031,694 53.3%   
"Free" reserves Rs m21,02515,735 133.6%   
Net worth Rs m21,92817,430 125.8%   
Long term debt Rs m11,3980-   
Total assets Rs m63,73431,930 199.6%  
Interest coverage x-0.1462.6 -0.0%   
Debt to equity ratio x0.50-  
Sales to assets ratio x0.61.0 56.8%   
Return on assets %0.519.1 2.5%  
Return on equity %-10.534.9 -30.2%  
Return on capital %-0.848.1 -1.6%  
Exports to sales %46.70-   
Imports to sales %048.1 0.0%   
Exports (fob) Rs m17,213NA-   
Imports (cif) Rs mNA15,630 0.0%   
Fx inflow Rs m18,1131,622 1,116.9%   
Fx outflow Rs m67215,630 4.3%   
Net fx Rs m17,442-14,008 -124.5%   
CASH FLOW
From Operations Rs m4444,842 9.2%  
From Investments Rs m3,0258,079 37.4%  
From Financial Activity Rs m-2,139-15,433 13.9%  
Net Cashflow Rs m1,328-2,512 -52.8%  

Share Holding

Indian Promoters % 27.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 38.9 11.6 335.6%  
FIIs % 19.5 2.9 663.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 72.6 25.0 290.4%  
Shareholders   91,182 114,663 79.5%  
Pledged promoter(s) holding % 69.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES PHARMA SCIENCE With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on STRIDES PHARMA SCIENCE vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

STRIDES PHARMA SCIENCE vs GSK Pharma Share Price Performance

Period STRIDES PHARMA SCIENCE GSK Pharma S&P BSE HEALTHCARE
1-Day 1.16% 3.26% 1.18%
1-Month 0.35% -9.77% -0.75%
1-Year 176.88% 52.63% 61.82%
3-Year CAGR -3.35% 10.89% 18.16%
5-Year CAGR 10.98% 8.44% 19.79%

* Compound Annual Growth Rate

Here are more details on the STRIDES PHARMA SCIENCE share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of STRIDES PHARMA SCIENCE hold a 27.4% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of STRIDES PHARMA SCIENCE and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, STRIDES PHARMA SCIENCE paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of -5.9%.

GSK Pharma paid Rs 32.0, and its dividend payout ratio stood at 89.2%.

You may visit here to review the dividend history of STRIDES PHARMA SCIENCE, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.